Download Free How Prescription And Over The Counter Drugs Affect Sexual Performance Book in PDF and EPUB Free Download. You can read online How Prescription And Over The Counter Drugs Affect Sexual Performance and write the review.

Most adults take at least one prescription medication for example, for high blood pressure, high cholesterol levels, depression, asthma, diabetes, COPD, or a variety of other reasons, but most people (and many healthcare providers) are totally unaware that medications can have direct negative effects on sexual functioning and performance. This informative and timely book written by three well-known medications experts explores the chemistry behind sexual arousal in men and women and clearly and authoritatively explains how the common categories of prescription and over-the-counter medications and abused substances might be the reason for their declining sexual performance or even interest.
A veteran board-certified pharmacist cites the high number of annual deaths associated with prescription drug side effects, calling for changes in prescription practices that account for the needs of aging bodies.
The area of human sexuality, and sexual dysfunction in particular, has been undergoing enormous developments and advances. This volume, written by a team of international experts in the area of sexology, is an authoritative review of the latest developments in this field. Areas such as evaluation of sexual dysfunction, impact of psychotropic medications, mental and physical illness and substance abuse on sexual functioning are covered in a highly informative manner. In addition, several sexual dysfunctions, namely hypoactive sexual desire disorder, male erectile disorder and premature ejaculation are reviewed. A chapter on the developments in imaging of sexual dysfunction, an area that is undergoing rapid expansion, is also included. This publication, filled with a variety of clinically essential information, provides psychiatrists, psychologists, sex therapists, urologists, gynecologists, both clinically and research oriented, with the latest developments in the area of sexual dysfunction.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
Sexual side effects of pharmacological agents are often an unspoken cause of treatment noncompliance.
Effects of Lifestyle on Men's Health provides an evidence-based review of the effects of modifiable risk factors such as sleep, diet, stress and exercise on various elements of men's health, notably sexual function, urinary function and cancer prevention and detection. Content highlights the most up-to-date basic and clinical information available, along with future research directions. Each chapter provides an easy to reference bullet point style summary to highlight the salient take-home messages from each section. Researchers and clinicians alike can use this book as a reference point for all matters related to lifestyle and men's health. - Offers an evidence-based review of the associations between modifiable risk factors (diet, lifestyle, sleep, environment and exercise) and men's health - Delivers examples of how changes to risk factors improve overall health - Provides insight into what the future of men's health holds in terms of basic and clinical research
An innovative, easily-accessible introduction to the subject for both clinicians and trainees. Illustrated throughout in colour, this handbook offers an invaluable visual lesson detailing data and information on all classes of antidepressants currently available.
Book Delisted
Major depressive disorders have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways hold promise as new therapeutics for depression. With the collaboration of the most prestigious international specialists in biochemistry, mol